The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Open accessAbstract
The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Seventeen (35%) of these subjects progressed from NGT to IGT and then to diabetes during follow up.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“During follow up, insulin secretion declined progressively by 78% while insulin sensitivity decreased by only 14%.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [10]
In the citing paper
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [20]
In the citing paper
“IGT and T2DM ensue when beta cell function fails to compensate.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
In the citing paper
“Insulin resistance precedes the development of hyperglycemia and T2DM and results in compensatory hyperinsulinemia.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Body composition from fluid spaces and density: analysis of methods. 1961.
Siri, W. E. (1994) · PubMed · Cited by 2,556
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 5×
“It is well known that there is a hyperbolic relationship between early insulin secretion and insulin action in individuals with NGT, meaning that, cross-sectionally, insulin secretion increases with decreasing insulin action and vice versa (51, 52).”
BackgroundMethodInfluentialTechniques for Measuring Body Composition
National Research Council (1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,620
Research works printed but not linked: 6
- 1998, Diabetes Care, 21(Suppl. 1), S5
- DeFronzo, 1997, Diabetes Reviews, 5, 177
- Abbott, 1990, Am J Physiol, 258, E347
- Bogardus, 1984, J Clin Invest, 78, 1568
- Schwartz, 1995, J Clin Endocrinol Metab, 80, 1571
- Luzi, 1989, Am J Physiol, 257, E241
Cited by
Sorted by citations
Items 501–600 of 1,002
Shaked, M., Ketzinel‐Gilad, M., Ariav, Y., Cerasi, E., Kaiser, Ν., & Leibowitz, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1274-2 · Cited by 57
Botanicals and the metabolic syndrome
Cefalu, W. T., Ye, J., Zuberi, A. R., Ribnicky, D., Raskin, I., Liu, Z., Wang, Z. Q., Brantley, P. J., Howard, L. R., & LeFevre, M. L. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.481s · Cited by 57
Badoud, F., Lam, K. P., Perreault, M., Zulyniak, M. A., Britz‐McKibbin, P., & Mutch, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134613 · Cited by 57
Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development
Liu, Y., Prentice, K. J., Eversley, J. A., Hu, C., Batchuluun, B., Leavey, K., Hansen, J. B., Wei, D. W., Cox, B., Dai, F. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.079 · Cited by 57
Histone deacetylase regulates insulin signaling via two pathways in pancreatic β cells
Kawada, Y., Asahara, S., Sugiura, Y., Sato, A., Furubayashi, A., Kawamura, M., Bartolomé, A., Terashi, E., Takai, T., Kanno, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184435 · Cited by 57
Laudes, M., Barroso, I., Luan, J., Soos, M. A., Yeo, G. S. H., Meirhaeghe, A., Logie, L., Vidal‐Puig, A., Schafer, A. J., Wareham, N. J., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.842 · Cited by 57
Lupi, R., Guerra, S. D., Mancarella, R., Novelli, M., Valgimigli, L., Pedulli, G. F., Paolini, M., Soleti, A., Filipponi, F., Mosca, F., et al. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.03.005 · Cited by 57
(How) Can We Prevent Type 2 Diabetes?
Buchanan, T. A. (2007) · Diabetes · doi:10.2337/db07-0140 · Cited by 57
Wolever, T. M. S., Rahn, M., Dioum, E. M., Spruill, S. E., Ezatagha, A., Campbell, J. E., Jenkins, A. L., & Chu, Y. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab154 · Cited by 56
The elusive cephalic phase insulin response: triggers, mechanisms, and functions
Langhans, W., Watts, A. G., & Spector, A. C. (2022) · Physiological Reviews · doi:10.1152/physrev.00025.2022 · Cited by 57
The role of insulin signaling in the development of β-cell dysfunction and diabetes
Wang, Q., & Jin, T. (2009) · Islets · doi:10.4161/isl.1.2.9263 · Cited by 56
Ning, F., Zhang, L., Dekker, J. M., Onat, A., Stehouwer, C. D. A., Yudkin, J. S., Laatikainen, T. K., Tuomilehto, J. O., Pyörälà, K., Qiao, Q., et al. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-76 · Cited by 56
Lin, E., Liang, Z., Frediani, J. K., Davis, S. S., Sweeney, J. F., Ziegler, T. R., Phillips, L. S., & Gletsu-Miller, N. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00405.2010 · Cited by 56
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
Chon, S., & Gautier, J. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.99 · Cited by 56
Hayashino, Y., Izumi, K., Okamura, S., Nishimura, R., Origasa, H., Tajima, N., & the JDCP study group (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12550 · Cited by 56
Wang, C., Zheng, L. P., Su, G., Zeng, X., Sun, B., & Zhao, M. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07687 · Cited by 56
Prediabetes remission to reduce the global burden of type 2 diabetes
Sandforth, L., Kullmann, S., Sandforth, A., Fritsche, A., von Schwartzenberg, R. J., Stefan, N., & Birkenfeld, A. L. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.01.004 · Cited by 55
Prediabetes as a Therapeutic Target
Pour, O. R., & Dagogo-Jack, S. E. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.149096 · Cited by 55
The Pancreatic β Cells in Human Type 2 Diabetes
Marchetti, P., Bugliani, M., Boggi, U., Masini, M., & Marselli, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_22 · Cited by 55
Nawrocka, D., Kornicka, K., Szydlarska, J., & Marycz, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3027109 · Cited by 56
Hanley, A. J., Zinman, B., Sheridan, P., Yusuf, S., Gerstein, H. C., & for the Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators (2009) · Diabetes Care · doi:10.2337/dc09-1579 · Cited by 55
Bunt, J. C., Krakoff, J. A., Ortega, E., Knowler, W. C., & Bogardus, C. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.686 · Cited by 54
Self-citationNovel phenotypes of prediabetes?
Häring, H. (2016) · Diabetologia · doi:10.1007/s00125-016-4015-3 · Cited by 54
Vettorazzi, J. F., Kurauti, M. A., Soares, G. M., Borck, P. C., Ferreira, S. M., Branco, R. C. S., Michelone, L. D. S. L., Boschero, A. C., Costa, J. M., & Carneiro, E. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13974-0 · Cited by 54
Efficacy and Safety of Nateglinide in Type 2 Diabetic Patients with Modest Fasting Hyperglycemia
Saloranta, C., Hershon, K. S., Ball, M., Dickinson, S., & Holmes, D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020068 · Cited by 54
Type 2 Diabetes, PUFAs, and Vitamin D: Their Relation to Inflammation
López, A. L. G., Valdés‐Ramos, R., & Martínez‐Carrillo, B. E. (2014) · Journal of Immunology Research · doi:10.1155/2014/860703 · Cited by 53
Effects of Age on Insulin Resistance and Secretion in Subjects without Diabetes
Oya, J., Nakagami, T., Yamamoto, Y., Fukushima, S., Takeda, M., Endo, Y., & Uchigata, Y. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1580 · Cited by 53
Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth
Weiss, R. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00336.x · Cited by 53
Genetics of Glucose Homeostasis
Norris, J. M., & Rich, S. S. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.255463 · Cited by 52
Harada, P. H. N., Demler, O., Dugani, S. B., Akinkuolie, A. O., Moorthy, M. V., Ridker, P. M., Cook, N. R., Pradhan, A. D., & Mora, S. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.06.008 · Cited by 52
Komada, H., Hirota, Y., So, A., Nakamura, T., Okuno, Y., Fukuoka, H., Iguchi, G., Takahashi, Y., Sakaguchi, K., & Ogawa, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00357 · Cited by 52
Whitticar, N. B., & Nunemaker, C. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00378 · Cited by 52
Drug-induced diabetes mellitus
Izzedine, H., Launay‐Vacher, V., Deybach, C., Bourry, E., Barrou, B., & Deray, G. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.6.1097 · Cited by 52
Pinelli, A., Godio, C., Laghezza, A., Mitro, N., Fracchiolla, G., Tortorella, V., Lavecchia, A., Novellino, E., Fruchart, J., Staels, B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0502844 · Cited by 52
Reduced Early Insulin Secretion in the Etiology of Type 2 Diabetes Mellitus in Pima Indians
Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s262 · Cited by 52
Self-citationJeppesen, C., Bjerregaard, P., & Jørgensen, M. E. (2013) · Public Health Nutrition · doi:10.1017/s136898001300013x · Cited by 52
A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice
Karasawa, H., Nagata-Goto, S., Takaishi, K., & Kumagae, Y. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.028 · Cited by 52
Knowles, N. G., Landchild, M. A., Fujimoto, W. Y., & Kahn, S. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.292 · Cited by 51
Tunaiji, H. A., Davis, J. C., Mackey, D. C., & Khan, K. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-469 · Cited by 51
Fayh, A. P. T., Lopes, A. L., Fernandes, P. R., Reischak-Oliveira, Á., & Friedman, R. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005442 · Cited by 51
Dixit, S. S., Wang, T., Manzano, E. J. Q., Yoo, S., Lee, J., Chiang, D. Y.-E., Ryan, N., Respress, J. L., Yechoor, V. K., & Wehrens, X. H. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058655 · Cited by 51
Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial
Dillard, T. H., Purnell, J. Q., Smith, M. D., Raum, W. J., Hong, D., Laut, J., & Patterson, E. J. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.09.027 · Cited by 51
Trites, M. J., & Clugston, R. D. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1151-z · Cited by 51
Kaiser, N., Yuli, M., Üçkaya, G., Oprescu, A. I., Berthault, M., Kargar, C., Donath, M. Y., Cerasi, E., & Ktorza, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.138 · Cited by 51
Das, S. K., Hasstedt, S. J., Zhang, Z., & Elbein, S. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.492 · Cited by 51
G�ke, B. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201050-00005 · Cited by 51
Goran, M. I., Shaibi, G. Q., Weigensberg, M. J., Davis, J. N., & Cruz, M. L. (2006) · International Journal of Pediatric Obesity · doi:10.1080/17477160600780423 · Cited by 50
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
Salvatore, T., Galiero, R., Caturano, A., Rinaldi, L., Criscuolo, L., Martino, A. D., Albanese, G., Vetrano, E., Catalini, C., Sardu, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010658 · Cited by 52
Ethnic‐specific Pathways to Obesity‐related Disease: The Hispanic vs. African‐American Paradox
Goran, M. I. (2008) · Obesity · doi:10.1038/oby.2008.423 · Cited by 50
Derosa, G., Ragonesi, P. D., Carbone, A., Fogari, E., Bianchi, L., Bonaventura, A., Romano, D., Cicero, A. F. G., & Maffioli, P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0278 · Cited by 50
Jiang, H., Feng, J., Du, Z., Zhen, H., Lin, M., Jia, S., Li, T., Huang, X., Östenson, C., & Chen, Z. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.04.010 · Cited by 50
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 50
Induction of ovulation in infertile women with hyperandrogenism and insulin resistance
Barbieri, R. L. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107627 · Cited by 50
Area-Level Socioeconomic Status and Incidence of Abnormal Glucose Metabolism
Williams, E. D., Magliano, D. J., Zimmet, P., Kavanagh, A. M., Stevenson, C., Oldenburg, B. F., & Shaw, J. E. (2012) · Diabetes Care · doi:10.2337/dc11-1410 · Cited by 50
Hjelmesaeth, J. S., Åsberg, A., Müller, F., Hartmann, A., & Jenssen, T. G. (2005) · Current Diabetes Reviews · doi:10.2174/1573399052952604 · Cited by 50
Shorter Sleep Duration is Associated with Decreased Insulin Sensitivity in Healthy White Men
Wong, P. M., Manuck, S. B., DiNardo, M. M., Korytkowski, M., & Muldoon, M. F. (2015) · Sleep · doi:10.5665/sleep.4402 · Cited by 49
Techno-Functional Properties and Applications of Inulin in Food Systems
Canazza, E., Grauso, M., Mihaylova, D. S., & Lante, A. (2025) · Gels · doi:10.3390/gels11100829 · Cited by 49
Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies
Meece, J. D. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167336 · Cited by 49
Tamboli, R. A., Breitman, I., Marks‐Shulman, P., Jabbour, K., Melvin, W. V., Williams, B., Clements, R. H., Feurer, I. D., & Abumrad, N. N. (2014) · Obesity · doi:10.1002/oby.20776 · Cited by 49
Khan, H. A., Sobki, S. H., Ekhzaimy, A. A., Khan, I., & Almusawi, M. A. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.05.027 · Cited by 49
Rosenstock, J., Shen, S. G., Gatlin, M. R., & Foley, J. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1529 · Cited by 49
Treating Postprandial Hyperglycemia Does Not Appear to Delay Progression of Early Type 2 Diabetes
Kirkman, M. S., Shankar, R. R., Shankar, S. S., Shen, C., Brizendine, E. J., Baron, A., & McGill, J. B. (2006) · Diabetes Care · doi:10.2337/dc06-0061 · Cited by 49
Strategies to prevent type 2 diabetes
Abuissa, H. S., Bell, D. S. H., & O’Keefe, J. H. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x50606 · Cited by 49
Somineni, R. P., Boivin, G. P., & Elased, K. M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0532 · Cited by 48
Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.
Spellman, C. (2010) · PubMed · Cited by 48
Wang, W., Zhong, X., & Guo, J. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4947 · Cited by 48
Androgen Excess Disorders in Women: The Severe Insulin-Resistant Hyperandrogenic Syndrome, HAIR-AN
Rager, K. M., & Omar, H. Α. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.23 · Cited by 48
Incretin Mimetics and DPP-IV Inhibitors: New Paradigms for the Treatment of Type 2 Diabetes
Hinnen, D., Nielsen, L. L., Waninger, A., & Kushner, P. (2006) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.19.6.612 · Cited by 48
The Role of Thiazolidinediones in the Treatment of Patients with Type 2 Diabetes Mellitus
Mooradian, A. D., Chehade, J. M., & Thurman, J. E. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201010-00002 · Cited by 48
Glucose regulation of β ‐cell stress in type 2 diabetes
Leibowitz, G., Bachar-Wikström, E., Shaked, M., Sinai, A., Ketzinel‐Gilad, M., Cerasi, E., & Kaiser, Ν. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01280.x · Cited by 47
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study
Russo, G. T., Giorda, C. B., Cercone, S., Nicolucci, A., Cucinotta, D., & on behalf of BetaDecline Study Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0109702 · Cited by 47
Jalil, A. M. M., Ismail, A., Chong, P. P., Hamid, M., & Kamaruddin, S. H. S. (2008) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.3419 · Cited by 47
Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?
Goodus, M. T., & McTigue, D. M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113160 · Cited by 47
Admin, A., Weitz, J., Jacques-Silva, C., Qadir, M. M. F., Umland, O., Pereira, E., QURESHI, F., Tamayo, A., Dominguez-Bendala, J., Rodriguez‐Diaz, R., et al. (2020) · Diabetes · doi:10.2337/db19-0687 · Cited by 47
Jia, G., Lockette, W. E., & Sowers, J. R. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00280.2020 · Cited by 47
Cefalu, W. T., Waldman, S. A., & Ryder, S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100156 · Cited by 47
Ostberg, J. E., Hosseinzadeh‐Attar, M. J., Mohamed‐Ali, V., & Conway, G. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1966 · Cited by 47
Adiponectin: linking the metabolic syndrome to its cardiovascular consequences
Rabin, K. R., Kamari, Y., Avni, I., Grossman, E., & Sharabi, Y. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.3.465 · Cited by 47
Beta-cell failure in the pathogenesis of type 2 diabetes mellitus
Steppel, J. H., & Horton, E. S. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0019-3 · Cited by 47
Insulin resistance and metformin in polycystic ovary syndrome
Ben‐Haroush, A., Yogev, Y., & Fisch, B. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2003.11.027 · Cited by 47
The potential of astragalus polysaccharide for treating diabetes and its action mechanism
Liu, S., Wang, L., Zhang, Z., Leng, Y., Yang, Y. X., Fu, X., Xie, H., Gao, H., & Xie, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1339406 · Cited by 46
Christoffersen, B. Ø., Gade, L. P., Golozoubova, V., Svendsen, O., & Raun, K. (2010) · Steroids · doi:10.1016/j.steroids.2010.04.004 · Cited by 46
Saad, R. J., Gungor, N., & Arslanian, S. A. (2005) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2005.00097.x · Cited by 46
Clamp Techniques in Paediatrics: What Have We Learned?
Arslanian, S. A. (2005) · Hormone Research in Paediatrics · doi:10.1159/000089313 · Cited by 46
Jang, J. S., Lee, J. S., Lee, J. H., Kwon, D. S., Lee, K. E., Lee, S. Y., & Hong, E. K. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0607-5 · Cited by 46
Interplays between drugs and the gut microbiome
Wan, Y., & Zuo, T. (2022) · Gastroenterology report · doi:10.1093/gastro/goac009 · Cited by 47
An islet in distress: β cell failure in type 2 diabetes
Ogihara, T., & Mirmira, R. G. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00021.x · Cited by 46
Remission of Type 2 Diabetes with Very Low-Calorie Diets—A Narrative Review
Juray, S., Axen, K. V., & Trasino, S. E. (2021) · Nutrients · doi:10.3390/nu13062086 · Cited by 45
Alonso, L. C., Watanabe, Y., Stefanovski, D., Lee, E. J., Singamsetty, S., Romano, L. C., Zou, B., García-Ocaña, A., Bergman, R. N., & O'Donnell, C. P. (2012) · Obesity · doi:10.1038/oby.2012.36 · Cited by 45
Do, O. H., Gunton, J. E., Gaisano, H. Y., & Thorn, P. (2016) · Diabetologia · doi:10.1007/s00125-016-3942-3 · Cited by 46
Feline comorbidities: Pathophysiology and management of the obese diabetic cat
Clark, M., & Hoenig, M. E. (2021) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x211021540 · Cited by 45
Stefan, N., Stumvoll, M., Weyer, C., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01290.x · Cited by 44
Self-citationNovel Meta-Analysis-Derived Type 2 Diabetes Risk Loci Do Not Determine Prediabetic Phenotypes
Staiger, H., Machicao, F. E., Kantartzis, K., Schäfer, S., Kirchhoff, K., Guthoff, M., Silbernagel, G., Stefan, N., Fritsche, A., & Häring, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003019 · Cited by 44
van Raalte, D. H., van Genugten, R. E., Eliasson, B., Möller-Goede, D. L., Mari, A., Tura, A., Wilson, C., Fleck, P. R., Taskinen, M., Smith, U., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0639 · Cited by 44
Pathophysiology of diabetes mellitus type 2: beyond the duo "insulin resistance-secretion deficit".
Boada, C. A. C., & Martínez-Moreno, J. M. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6717 · Cited by 44
Bach1 deficiency protects pancreatic β-cells from oxidative stress injury
Kondo, K., Ishigaki, Y., Gao, J., Yamada, T., Imai, J., Sawada, S., Muto, A., Oka, Y., Igarashi, K., & Katagiri, H. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2013 · Cited by 44
Stefan, N., Stümvoll, M., Bogardus, C., & Tataranni, P. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00427.2002 · Cited by 44
Self-citationPratley, R. E., & Weyer, C. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0090-6 · Cited by 44
Self-citationHong, Y., Weisnagel, S. J., Rice, T., Sun, G., Mandel, S., Gu, C. C., Rankinen, T., Gagnon, J., Leon, A. S., Skinner, J. S., et al. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600104.x · Cited by 44
Skytte, M. J., Samkani, A., Astrup, A. V., Frystyk, J., Rehfeld, J. F., Holst, J. J., Madsbad, S., Burling, K., Fenger, M., Thomsen, M. N., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2020 · Cited by 43
Metadata
- Authors
- Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weyer, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 787-794
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408438
- OpenAlex
- W2077149049
- Cited by
- 1,940
- References
- 68
- Citations by year
- 2026: 24 · 2025: 53 · 2024: 53 · 2023: 74 · 2022: 63 · 2021: 80 · 2020: 64 · 2019: 64 · 2018: 61 · 2017: 72 · 2016: 88 · 2015: 81 · 2014: 91 · 2013: 85 · 2012: 83
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, impaired glucose tolerance, Pima Indians, insulin-stimulated glucose disposal, weight gain, diabetes prevention, pathogenesis
- MeSH terms
- Insulin Secretion, Adult, Anthropometry, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Obesity, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
